Multidisciplinary Training Program in Pediatric Pulmonary

小儿肺科多学科培训计划

基本信息

  • 批准号:
    9068331
  • 负责人:
  • 金额:
    $ 20.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-01 至 2018-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goals of the Johns Hopkins Multidisciplinary Training Program in Pediatric Pulmonary Medicine (T-32) are: (1) to produce outstanding biomedical scientists who will investigate the pathophysiology and treatment of pediatric pulmonary disorders; (2) to encourage and enable post-doctoral fellows to pursue academic careers in clinical and biomedical research; and (3) to develop national leaders in pediatric Pulmonology. It is committed to equal opportunity for its faculty, staff and students and, as a matter of policy, does not discriminate on the basis of any legally protected characteristics. The proposed training program will provide three years of training in pediatric lung-related research at the postdoctoral level for four qualified candidates with MD, MD/PhD, DO, or PhD degrees/year. This training program is the result of an extensive collaboration between thirty-four research faculty members in the Johns Hopkins School of Medicine's Departments of Pediatrics and Medicine and the Johns Hopkins Bloomberg School of Public Health. These research scientists offer mentored training in six Research Discipline Groups: (1) lung injury and development; (2) epithelial transport, lung transplantation and cystic fibrosis; (3) sleep disorder; (4) clinical outcomes in pediatric pulmonary diseases; (5) infectious diseases, tuberculosis and global health; and (6) asthma, allergy and inflammation. Postdoctoral trainees who wish to focus their research in the clinical sciences will be able to obtain a masters' degree (MPH or MHS) in graduate training programs in Clinical Investigations, Epidemiology, Biostatistics or Health Policy through the Johns Hopkins University Bloomberg School of Public Health. The tutorial relationship between research mentor and trainee will be central to the program's research training experience. This will be supplemented by coursework, formal training in the preparation of grant applications, formal training in the responsible conduct of research, active participation in program-wide conferences, presentation of original research at national scientific meetings and publication of original research in peer- reviewed journals. The Program Director will have the overall responsibility for assuring proper coordination of the program, including its educational, scientific, and administrative aspects. She will receive consultation from Executive, Program Advisory, Fellowship Review, Scholarship Review, Minority Advisory and External Advisory Committees. The Program Director will be assisted in the day-to-day operations of the program by the Chair of the Fellowship Review Committee, who will oversee the research training of this T-32 program. The program Director will also be assisted by the Director of this ACGME-accredited clinical training program. The Division Administrator will also provide skilled assistance to the program Director in the day-to-day management of this training grant. Although only nine years old, the current T-32 training program has already graduated 8 highly trained researchers in pediatric Pulmonology, seven of whom are currently faculty members in academic institutions in the U.S. This high performance standard will be continued in the proposed program. (End of Abstract)
描述(由申请人提供):约翰·霍普金斯(John Hopkins)多学科培训计划的儿科肺医学培训计划(T-32)是:(1)生产出色的生物医学科学家,他们将研究儿科肺部疾病的病理生理学和治疗; (2)鼓励并使博士后研究员从事临床和生物医学研究的学术职业; (3)发展小儿肺病学领导者。它致力于为其教职员工和学生提供平等的机会,并且根据政策,并没有根据任何受法律保护的特征来歧视。拟议的培训计划将在博士后研究小儿肺有关的研究三年培训,以使用MD,MD/PHD,DO或PHD学位/年度的四名合格候选人/年。该培训计划是约翰·霍普金斯医学学院儿科和医学系与约翰·霍普金斯彭博公共卫生学院的约翰·霍普金斯医学学院的三十四名研究教师之间进行广泛合作的结果。这些研究科学家在六个研究学科组中提供了受过指导的培训:(1)肺损伤和发育; (2)上皮运输,肺移植和囊性纤维化; (3)睡眠障碍; (4)小儿肺部疾病的临床结局; (5)传染病,结核病和全球健康; (6)哮喘,过敏和炎症。希望将研究重点放在临床科学上的博士后学员将能够在临床调查,流行病学,生物统计学或卫生政策的研究生培训计划中获得硕士学位(MPH或MHS)。 。研究导师与学员之间的教程关系将是该计划的研究培训经验的核心。这将通过课程,正规培训进行补充,以准备赠款申请,负责任进行研究,积极参与的正式培训 在范围内的会议上,在国家科学会议上介绍了原始研究,并在同行评审期刊上发表了原始研究。该计划主管将负责确保该计划的适当协调,包括其教育,科学和行政方面。她将获得高管,计划咨询,奖学金审查,奖学金审查,少数民族咨询和外部咨询委员会的咨询。奖学金审查委员会主席将在计划的日常运营中协助该计划主任,该委员会将监督该T-32计划的研究培训。该计划主管还将由ACGME认可的临床培训计划的主任协助。该部门管理员还将在该培训赠款的日常管理中为计划主任提供熟练的帮助。尽管只有9岁,目前的T-32培训计划已经毕业了8位训练有素的小儿肺病研究人员,其中7名目前是美国学术机构的教职员工,该高性能标准将在拟议的计划中继续进行。 (抽象的结尾)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharon Ann McGrath-Morrow其他文献

Sharon Ann McGrath-Morrow的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharon Ann McGrath-Morrow', 18)}}的其他基金

Multidisciplinary Training Program in Pediatric Lung Diseases
小儿肺部疾病多学科培训计划
  • 批准号:
    10332256
  • 财政年份:
    2022
  • 资助金额:
    $ 20.77万
  • 项目类别:
Multidisciplinary Training Program in Pediatric Lung Diseases
小儿肺部疾病多学科培训计划
  • 批准号:
    10594441
  • 财政年份:
    2022
  • 资助金额:
    $ 20.77万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    8680365
  • 财政年份:
    2013
  • 资助金额:
    $ 20.77万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    9769845
  • 财政年份:
    2013
  • 资助金额:
    $ 20.77万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    9613428
  • 财政年份:
    2013
  • 资助金额:
    $ 20.77万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    10226540
  • 财政年份:
    2013
  • 资助金额:
    $ 20.77万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    8502861
  • 财政年份:
    2013
  • 资助金额:
    $ 20.77万
  • 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
  • 批准号:
    10245317
  • 财政年份:
    2013
  • 资助金额:
    $ 20.77万
  • 项目类别:
NIGHTTIME HYPOXEMIA IN TEENAGERS WITH ATAXIA TELANGIECTASIA
毛细血管扩张性共济失调青少年的夜间低氧血症
  • 批准号:
    7604677
  • 财政年份:
    2006
  • 资助金额:
    $ 20.77万
  • 项目类别:
REGULATION OF GROWTH ARREST IN HYPEROXIC NEONATAL LUNG
高氧新生儿肺生长停滞的调节
  • 批准号:
    2027141
  • 财政年份:
    1997
  • 资助金额:
    $ 20.77万
  • 项目类别:

相似国自然基金

ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
PRDX6增强铁蛋白稳定性抑制铁自噬减轻慢阻肺上皮细胞铁死亡的作用及机制研究
  • 批准号:
    82370048
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
DsbA-L促进肺泡上皮细胞铁死亡加重脓毒症肺损伤的机制研究
  • 批准号:
    82360377
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
急性肺损伤中Hippo通路调控肺泡中间过渡态上皮细胞再生分化机制研究
  • 批准号:
    82372185
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
布洛芬通过线粒体超极化损伤早产儿肺血管发育的机制及干预研究
  • 批准号:
    82371707
  • 批准年份:
    2023
  • 资助金额:
    65 万元
  • 项目类别:
    面上项目

相似海外基金

Mechanistic Study of Inspiratory Training in Childhood Asthma
儿童哮喘吸气训练机制研究
  • 批准号:
    10637048
  • 财政年份:
    2023
  • 资助金额:
    $ 20.77万
  • 项目类别:
Development and implementation of a digital sleep intervention for preschoolers in foster care
为寄养中的学龄前儿童开发和实施数字睡眠干预
  • 批准号:
    10724304
  • 财政年份:
    2023
  • 资助金额:
    $ 20.77万
  • 项目类别:
Improving Prediction of Asthma-related Outcomes with Genetic Ancestry-informed Lung Function Equations
利用遗传祖先信息的肺功能方程改善哮喘相关结果的预测
  • 批准号:
    10723861
  • 财政年份:
    2023
  • 资助金额:
    $ 20.77万
  • 项目类别:
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
利用诱导多能干细胞研究肺泡2型细胞功能障碍在肺纤维化中的作用
  • 批准号:
    10591174
  • 财政年份:
    2023
  • 资助金额:
    $ 20.77万
  • 项目类别:
Urban rat exposure and pediatric asthma
城市老鼠暴露与小儿哮喘
  • 批准号:
    10723612
  • 财政年份:
    2023
  • 资助金额:
    $ 20.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了